11/30/2016Balancing Act: China's Online Healthcare System Needs Both Innovation ...

11/30/2016MicuRx Initiates Phase 1 Clinical Trial in U.S. for Novel Antibiotic A...

11/30/2016Beijing Uniforms BMI Drug Reimbursement of Hospitals and Community Hea...

11/29/2016Senior Local Health Official Investigated for Corruption

11/29/2016CBMG to Commence Phase I Trial in China for Non-Hodgkin Lymphoma Drug

11/29/2016China Sees Continued Rising HIV/AIDS Cases in 2016

11/29/2016AstraZeneca Adopts “Lean In” Strategy in China as Business Grows 15%...

11/29/2016U.S. FDA Warns Chinese Heparin Producer Dongying Tiandong Pharma

11/29/2016CFDA Solicits Comments on New Policy for Reference Drug Selection in G...

11/29/2016CFDA Seeks Comments on New Policy over Classification of Generic Drugs...

11/29/2016Innovent Biologics Raises $260M in Series D Financing

11/29/2016Upcoming Event: 15th Annual eyeforpharma Barcelona 2017

11/28/2016Boehringer Ingelheim and China Southeast University Join Hands for Hea...

11/28/2016CFDA Issues Announcement over Dossier Requirements for Pharma Packagin...

11/28/2016CFDA Issues Announcement for Drug Registration Application Disk Submis...

11/28/2016Zhejiang Introduces New Public Hospital Drug Purchase Policy Allowing ...

11/28/2016China Releases New Guideline to Boost Property Right Protection

11/28/2016Upcoming Event: 3rd Annual Asia Healthcare Summit 2017

11/26/2016Official: CFDA in Critical Stage of Drug Administration Law Revision

11/26/2016Recent Executive Moves

11/26/2016SMEI: Chinese Pharma e-Commerce to Continue High Growth

11/26/2016Facing A 'Tidal Wave' of Dementia, China Is Running Out of Time

11/26/2016Ali Health Gears Up Pharma e-Commerce Expansion in China

11/26/2016BMS to Center China Business on Immuno-oncology

11/26/2016Suven Life Sciences Granted One More NCE Product Patent in China for N...

11/26/2016Indigenously-developed Long-acting AIDS Drug Under Final Review in Chi...

11/26/2016Pfizer, Astrazeneca Outpace Big Pharma in Emerging Markets as Growth T...

11/25/2016Shenzhen Hepalink Invests $36.5M into Bristish Biotech Kymab

11/25/2016Fitch: Margin Pressure and Consolidation for China's Pharma Distributo...

11/24/2016SIPO Revises Chinese Patent Examination Regulations

Page:380/774 Total number of articles:23207: [First][<<] [378] [379] [380] [381] [382] [>>] [End]